Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience-Reference-Cited by-同舟云学术

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience

Published:2020-02 Issue:2 Volume:20 Page:105-113
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Sobas Marta,Czyż Anna,Montesinos Pau,Armatys Anna,Helbig Grzegorz,Hołowiecka Aleksandra,Pluta Agnieszka,Zarzycka Ewa,Piątkowska-Jakubas Beata,Majcherek Maciej^ORCID,Lewandowski Krzysztof,Gołos Aleksandra,Paluszewska Monika,Podhorecka Monika,Oleksiuk Jolanta,Skręt Anna,Hawrylecka Dorota,Guzicka-Kazimierczak Renata Ewa,Wątek Marzena,Gromek Tomasz,Charliński Grzegorz,Grosicki Sebastian,Holojda Jadwiga,Miśkiewicz Wojciech,Martinez-Cuadrón David,Sanz Miguel Angel,Wróbel Tomasz,Wierzbowska Agnieszka,Giebel Sebastian

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. Acute promyelocytic leukemia: recent advances in diagnosis and management;Lo-Coco;Semin Oncol,2008

2. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Sanz;Blood,2009

3. A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group;Fenaux;Blood,1999

4. Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group;Sanz;Blood,2004

5. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome;Sanz;Blood,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide;Annals of Hematology;2024-04-29

2. The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management;Cancers;2023-07-03

3. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia;BMC Cancer;2023-01-07

4. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience;Romanian Journal of Internal Medicine;2020-08-10